Ira Duarte Email Address

Chief Financial Officer

Veloxis Pharmaceuticals (LCP) is an emerging specialty pharmaceutical company, focused on certain cardiovascular indications and organ transplantation in particular. The intention is to approach the transplantation market through our own, hospital-based specialist sales force and to use marketing and sales partners for the cardiovascular indications. We believe that our proprietary MeltDose(r) technology platform enables us to develop drugs which achieve the same efficacy as currently commercialized drugs, but at lower doses. The results are generally better bioavailability, a reduction in potential interaction with food and other drugs, and in some cases, reduced side effects.

Hands-on and team-oriented senior finance professional with over 18 years of experience in finance, accounting and auditing leadership roles, including five years with a $160M+ publicly-traded pharmaceutical company and nine years as an auditor with a leading Big Four public accounting firm. An energetic, self-starter with a strong work ethic and high level of professionalism. Proven leadership skills with a strategic mindset and strong analytical skills.CORE LEADERSHIP COMPETENCIES:- General Ledger Accounting- SEC Regulatory Compliance- Financial Reporting- Strategic Finance Planning- Working Capital Management- Mergers and Acquisitions (M&A)- Financial Planning, Budgeting, Forecasting and Analysis - Internal Controls / Sarbanes-Oxley